Trump Reveals Temu Oddjob Is “Taking Fat Drugs”
The Daily Beast reports: Donald Trump has outed White House communications chief and resident attack dog Steven Cheung as a user of “fat drugs.” Announcing plans to slim down the cost of popular weight loss drugs, the president began naming his cabinet members and aides, asking if they needed such medication. “You taking any of […]
Trump makes deal to lower price of obesity drugs from Eli Lilly and Novo Nordisk
The Trump administration made a deal with pharmaceutical giants Eli Lilly and Novo Nordisk to lower prices for blockbuster anti-obesity and diabetes medications in the GLP-1 drug class, as well as expand coverage access for Medicare beneficiaries. The deal means the revolutionary drugs will be covered for Medicare patients struggling with obesity. Administration officials also […]
Trump unveils deal to lower prices for breakthrough weight-loss drugs
The deal could expand coverage and lower the price of GLP-1 medications for millions of Americans.
Pharmaceutical Rep Collapses in Oval Office During Trump Weight Loss Drug Press Conference | Video
A pharmaceutical rep collapsed in the Oval Office on Thursday right as Eli Lilly‘s David Ricks was discussing a weight loss drug deal during a press conference with President Donald Trump. “A representative with one of the companies fainted. The White House Medical Unit quickly jumped into action and the gentleman is okay,” Press Secretary Karoline Leavitt […]
Trump unveils deal with Eli Lilly and Novo Nordisk to lower costs and expand coverage for obesity drugs
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years. But access to […]
President Trump unveils deal to expand coverage, lower costs on GLP-1 obesity drugs like Wegovy – News4JAX
President Trump unveils deal to expand coverage, lower costs on GLP-1 obesity drugs like Wegovy News4JAX
Some Patients Can Maintain Health Gains After Reducing GLP-1 Dose Frequency
(MedPage Today) — Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to maintain their improvements in weight, body composition, and metabolic improvements after they reduced the…
Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook – Yahoo Finance
Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook Yahoo Finance Novo Nordisk CFO outlines ‘ultimate defense’ against stock downgrades and lawsuits to retain weight-loss crown Fortune Novo Nordisk Is Seeing Slowing Demand for GLP-1s Wegovy and Ozempic Yahoo Finance Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly Reuters After shaky […]
Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here’s What Investors Need to Know.
Key Points Sluggish growth for Novo Nordisk’s GLP-1 drugs caused the company to again reduce its full-year sales guidance. Novo Nordisk faces challenges from the continued compounding of GLP-1 drugs and increased competition. The company hopes to change its fortunes with the approval of a Wegovy pill and the acquisition of Metsera. 10 stocks we […]
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
President Donald Trump has announced a landmark deal aiming to expand Medicare coverage to include certain weight-loss medications, a move that could dramatically change access to these treatments for millions of older Americans. On November 6, Trump revealed that his administration had struck agreements with Eli Lilly and Novo Nordisk, the makers of popular weight-loss […]